Maia Biotechnology
NYSE MAIA · Chicago, IL
Works in Oncology · Respiratory
Maia Biotechnology is a clinical trial sponsor based in Chicago, IL, listed as NYSE MAIA. It has 2 active clinical trials with 527 planned participants, in Oncology and Respiratory.
Trial track record · since 2021
Financials · NYSE MAIA
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Maia Biotechnology
Maia Biotechnology is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 527 planned participants, in Oncology, Respiratory. Since 2021 it has completed 0 trials and stopped 0 early.
Maia Biotechnology is based in Chicago, IL and is listed as NYSE MAIA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Maia Biotechnology; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-16.
Approve Suite is not affiliated with Maia Biotechnology.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.